Cipla Ltd. - Financial Analysis Review
Summary
Cipla Ltd. (Cipla) is a pharmaceutical company. It offers various drugs and healthcare products. The company manufactures and sells various OTC products, prescription products, flavors and fragrances, pesticides, and animal products. They are offered in the form of tablets, capsules, injection, suspension, syrup, and disp tablet. Cipla exports its products to 170 countries across the globe. The company’s products are certified by various recognized regulatory authorities namely Food and Drug Administration (FDA), USA; Medicines and Healthcare products Regulatory Agency (MHRA), UK and so on. It has various manufacturing facilities and R&D centers located across India.
Global Markets Direct’s "Cipla Ltd. - Financial Analysis Review” is an in-depth business and financial analysis of Cipla Ltd.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.
And More inside the report…
Recent Developments
Nov 11, 2009: Cipla Launches Flu Drug Oseltamivir
Scope
- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.
Report HighlightsThe following companies are the major competitors of Cipla Ltd.:
GlaxoSmithkline Consumer Healthcare Ltd.
Ranbaxy Laboratories Limited
[Cerrar las informaciones del articulo de mercado]
